-
T-cell and antibody responses in immunocompromised patients with hematologic malignancies indicate strong potential of SARS-CoV-2 mRNA vaccines
Pothast, C. R., Hofsink, Q., Haggenburg, S., Dijkland, R. C., van de Meent, M., van Dijk, K., Bhoekhan, M. S., Haverkate, N. J. E., van Meerloo, J., Falkenburg, J. H. F., de Groen, R. A. L., Broers, A. E. C., van Doesum, J. A., van Binnendijk, R. S., den Hartog, G., Lissenberg-Witte, B. I., Kater, A. P., Smits, G. P., Wouters, D. & van Leeuwen, E. M. M. & 13 others, , 1 Nov 2025, In: Haematologica. 110, 11, p. 2799-2805Research output: Contribution to journal › Article › Academic › peer-review
-
Fourth mRNA COVID-19 vaccination in immunocompromised patients with haematological malignancies (COBRA KAI): a cohort study
COBRA KAI Study Team, 1 Jul 2023, In: EClinicalMedicine. 61, 102040.Research output: Contribution to journal › Article › Academic › peer-review
-
Human Dendritic Cells Transmit Enterovirus A71 via Heparan Sulfates to Target Cells Independent of Viral Replication
Helgers, L. C., Bhoekhan, M. S., Pajkrt, D., Wolthers, K. C., Geijtenbeek, T. B. H. & Sridhar, A., 1 Nov 2022, In: Microbiology spectrum. 10, 6, p. e0282222Research output: Contribution to journal › Article › Academic › peer-review
- All publications
